Latest Operational Infrastructure News

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

Caravel Minerals has initiated the engineering tendering process for its Caravel Copper Project, aiming to award contracts from August 2025. This follows a simplified plant design and a $15 million loan facility, positioning the project for streamlined development.

Winsome Resources has received crucial Environmental and Social Impact Assessment guidelines from Québec authorities, marking a significant regulatory milestone for its Adina Lithium Project. This development sets the stage for detailed environmental studies and stakeholder engagement ahead of the project's next phase.

SRG Global has locked in $850 million worth of contracts spanning water, energy, resources, and more, reinforcing its position as a diversified infrastructure leader in Australia and New Zealand.

Wiseway Group Limited will seek retrospective shareholder approval for critical related party leases after ASX determines prior approvals were required. The company assures operations remain unaffected as it commissions an independent fairness report.

Genetic Technologies Limited has signed binding term sheets to acquire Ellerfield Wealth and Walker Capital, marking a strategic shift into wealth management backed by a $7.8 million valuation and pending ASX approvals.

Chilwa Minerals has received final assay results from 107 sonic drillholes at its Mposa Deposit, revealing significant heavy mineral grades that underpin an updated resource estimate. Drilling has now commenced at the Northern Shore Halalla deposit as the company advances its mining licence and development plans.

Super Retail Group reports steady sales growth driven by BCF and rebel brands, while facing increased costs from a new distribution centre and HR system upgrades.

Nuchev Limited has entered an exclusive sales agency agreement with Brauer Natural Medicines and H&S Brand Corporation, expanding its footprint in Australia's natural and complementary medicines sector. The deal covers key brands including Brauer, Skin Physics, and Rapid Loss, with potential for broader ANZ distribution.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.

Weebit Nano has marked a pivotal quarter by achieving automotive-grade AEC-Q100 qualification for its ReRAM technology, advancing integration with semiconductor giant onsemi, and securing a robust cash position to fuel growth.